BioAtla Inc
For the period ended Dec 31, 2023. Filed Mar 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 26, 2024
BCAB$1.74-44.7%Stored close · as of Aug 28, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
| Page | |
|---|---|
| Index to financial statements | |
| Report of independent registered public accounting firm (PCAOB ID: 42) | 77 |
| Balance sheets | 78 |
| Statements of operations and comprehensive loss | 79 |
| Statements of stockholders’ equity | 80 |
| Statements of cash flows | 81 |
| Notes to financial statements | 82 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.